Narrative review of non-pharmaceutical behavioural measures for the prevention of COVID-19 (SARS-CoV-2) based on the Health-EDRM framework

Br Med Bull. 2020 Dec 15;136(1):46-87. doi: 10.1093/bmb/ldaa030.

Abstract

Introduction: Non-pharmaceutical measures to facilitate a response to the COVID-19 pandemic, a disease caused by novel coronavirus SARS-CoV-2, are urgently needed. Using the World Health Organization (WHO) health emergency and disaster risk management (health-EDRM) framework, behavioural measures for droplet-borne communicable diseases and their enabling and limiting factors at various implementation levels were evaluated.

Sources of data: Keyword search was conducted in PubMed, Google Scholar, Embase, Medline, Science Direct, WHO and CDC online publication databases. Using the Oxford Centre for Evidence-Based Medicine review criteria, 10 bottom-up, non-pharmaceutical prevention measures from 104 English-language articles, which published between January 2000 and May 2020, were identified and examined.

Areas of agreement: Evidence-guided behavioural measures against transmission of COVID-19 in global at-risk communities were identified, including regular handwashing, wearing face masks and avoiding crowds and gatherings.

Areas of concern: Strong evidence-based systematic behavioural studies for COVID-19 prevention are lacking.

Growing points: Very limited research publications are available for non-pharmaceutical measures to facilitate pandemic response.

Areas timely for research: Research with strong implementation feasibility that targets resource-poor settings with low baseline health-EDRM capacity is urgently needed.

Keywords: COVID-19; SARS-CoV-2; behavioural measures; biological hazards; coronavirus; droplet-borne; health-EDRM; non-pharmaceutical; pandemic; primary prevention.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Attitude to Health
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • COVID-19* / psychology
  • Disease Transmission, Infectious / prevention & control*
  • Health Promotion / methods*
  • Humans
  • Outcome Assessment, Health Care / methods*
  • Primary Prevention / methods*
  • Risk Reduction Behavior
  • SARS-CoV-2